ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease

Dong Hun Lee,Tae Min Kim,Joo Kyung Kim,Changwon Park
DOI: https://doi.org/10.7150/thno.35300
IF: 11.6
2019-01-01
Theranostics
Abstract:Cardiovascular diseases have long been the leading cause of mortality and morbidity in the United States as well as worldwide. Despite numerous efforts over the past few decades, the number of the patients with cardiovascular disease still remains high, thereby necessitating the development of novel therapeutic strategies equipped with a better understanding of the biology of the cardiovascular system. Recently, the ETS transcription factor, ETV2 (also known as ER71), has been recognized as a master regulator of the development of the cardiovascular system and plays an important role in pathophysiological angiogenesis and the endothelial cell reprogramming. Here, we discuss the detailed mechanisms underlying ETV2/ER71-regulated cardiovascular lineage development. In addition, recent reports on the novel functions of ETV2/ER71 in neovascularization and direct cell reprogramming are discussed with a focus on its therapeutic potential for cardiovascular diseases.
medicine, research & experimental
What problem does this paper attempt to address?